ArticleJournal of clinical microbiology2014
Occurrence of Ochroconis and Verruconis species in clinical specimens from the United States.
Article in Journal of clinical microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 58 citations in OpenAlex.
- New additions toMycoKeys · 2026Article
- Two novel species ofMycoKeys · 2026Article
- Revealing the Hidden Diversity of Aquatic and Terrestrial Fungi in Korea: 17 Newly Recorded Species.Mycobiology · 2026Article
- PulmonaryJournal of fungi (Basel, Switzerland) · 2025Article
- Case report: contamination of a drinking water distribution system byJournal of water and health · 2025Article
- Morphology and molecular phylogeny ofFrontiers in cellular and infection microbiology · 2025Article
- Recurrent Verruconis gallopava Infection at One Year after Excision of a Solitary Pulmonary Lesion.Internal medicine (Tokyo, Japan) · 2024Article
- Changes in fungal taxonomy: mycological rationale and clinical implications.Clinical microbiology reviews · 2023Review
- Unusual manifestation of pulmonaryBMJ case reports · 2023Article
- Answer to July 2023 Photo Quiz.Journal of clinical microbiology · 2023Article
- Fungal Nomenclature: Managing Change is the Name of the Game.Open forum infectious diseases · 2023Review
- Two new species ofMycoKeys · 2023Article
- Compartment and Plant Identity Shape Tree Mycobiome in a Subtropical Forest.Microbiology spectrum · 2022Article
- RE-EVALUATION OFPersoonia · 2022Article
- Isolation and molecular characterization of clinical and environmental dematiaceous fungi and relatives from Iran.Current medical mycology · 2021Article
- The Genera of Fungi - G6:Fungal systematics and evolution · 2020Article
- Article
- New and Interesting Fungi. 2.Fungal systematics and evolution · 2019Article
- Genome-resolved metagenomics of eukaryotic populations during early colonization of premature infants and in hospital rooms.Microbiome · 2019Article
- Two new species ofMycoKeys · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ochroconis is a dematiaceous fungus able to infect immunocompetent people. Recently, the taxonomy of the genus has been reevaluated, and the most relevant species, Ochroconis gallopava, was transferred to the new genus Verruconis. Due to the important clinical implications of these fungi and based on the recent classification, it was of interest to know the spectra of Ochroconis and Verruconis species in clinical samples received in a reference laboratory in the United States. A set of 51 isolates was identified morphologically and molecularly based on sequence analyses of the nuclear ribosomal RNA (nrRNA), actin, and β-tubulin genes. Verruconis gallopava was the most common species (68.6%), followed by Ochroconis mirabilis (21.5%). One isolate of Ochroconis cordanae was found, being reported for the first time in a clinical setting. The most common anatomical site of isolation was the lower respiratory tract (58.8%), followed by superficial and deep tissues at similar frequencies (21.6 and 19.6%, respectively). Interestingly, three new species were found, which are Ochroconis olivacea and Ochroconis ramosa from clinical specimens and Ochroconis icarus of an environmental origin. The in vitro antifungal susceptibilities of eight antifungal drugs against the Ochroconis isolates revealed that terbinafine and micafungin were the most active drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.